학술논문

Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer: Primary results from the phase III NATALEE trial.
Document Type
Article
Source
Journal of Clinical Oncology; 6/10/2023 Supplement17, Vol. 41, pLBA500-LBA500, 1p
Subject
Language
ISSN
0732183X